Biogen Inc.

NASDAQ: BIIB · Real-Time Price · USD
137.25
2.31 (1.71%)
At close: Aug 15, 2025, 12:31 PM

Biogen Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
10B 9.82B 9.68B 9.61B 9.67B 9.66B 9.84B 9.99B 9.97B 10.1B 10.17B 10.36B 10.63B 10.82B 10.98B 11.1B 11.7B 12.6B
Cost of Revenue
2.46B 2.4B 2.31B 2.35B 2.37B 2.41B 2.53B 2.49B 2.3B 2.19B 2.28B 2.37B 2.41B 2.39B 2.11B 1.94B 1.88B 1.83B
Gross Profit
7.54B 7.42B 7.37B 7.26B 7.31B 7.25B 7.3B 7.51B 7.68B 7.92B 7.9B 8B 8.22B 8.43B 8.87B 9.16B 9.82B 10.78B
Operating Income
2.42B 2.27B 2.23B 2.2B 1.7B 1.62B 1.56B 1.67B 2.49B 2.78B 2.87B 2.93B 2.9B 2.48B 2.84B 1.92B 2.22B 3.7B
Interest Income
86.3M 74.1M 67.6M 72.9M 157.2M 213M 276.5M 302.6M 230.6M 167.3M 89.3M 42.2M 20.9M 11M 11M 12.2M 15.6M 20.5M
Pretax Income
1.8B 1.75B 1.91B 1.91B 1.31B 1.32B 1.3B 1.61B 3.12B 3.68B 3.59B 3.39B 2.31B 1.63B 1.75B 1.69B 2.36B 3.82B
Net Income
1.53B 1.48B 1.63B 1.62B 1.16B 1.17B 1.16B 1.46B 2.66B 3.13B 3.05B 2.86B 2.06B 1.45B 1.56B 1.55B 1.92B 3.01B
Selling & General & Admin
2.42B 2.39B 2.4B 2.33B 2.53B 2.53B 2.55B 2.57B 2.35B 2.37B 2.4B 2.56B 2.65B 2.71B 2.67B 2.69B 2.61B 2.53B
Research & Development
1.91B 2.02B 2.03B 2.15B 2.34B 2.41B 2.54B 2.49B 2.31B 2.25B 2.23B 2.33B 2.48B 2.54B 2.5B 3.53B 3.97B 4.03B
Other Expenses
783.7M 727.1M 701.1M 623.7M 124.1M 84.6M 48M 127.3M 529.1M 516.2M 358.5M 147.5M 162.3M 672.6M 855.8M 1.07B 1.08B 564.4M
Operating Expenses
5.12B 5.14B 5.14B 4.97B 5.19B 5.22B 5.33B 5.52B 5.18B 5.14B 4.99B 5.04B 5.29B 5.94B 6.04B 7.3B 7.67B 7.12B
Interest Expense
252.4M 241.1M 250.3M 261.8M 265.8M 253.6M 246.9M 230.2M 226.3M 243M 246.6M 258.1M 264.5M 255.1M 253.7M 243.4M 233.4M 243M
Selling & Marketing Expenses
n/a n/a n/a 71.4M 71.4M 71.4M 71.4M 54.1M 54.1M 54.1M 54.1M 98.7M 98.7M 98.7M 98.7M 111.8M 111.8M 111.8M
Cost & Expenses
7.57B 7.54B 7.45B 7.37B 7.7B 7.77B 8B 8.09B 7.48B 7.3B 7.29B 7.43B 7.74B 8.36B 8.14B 9.17B 9.46B 8.9B
Income Tax Expense
267.2M 273.1M 273.8M 291.7M 156.3M 156M 135.3M 146.9M 456M 557.9M 632.8M 1.02B 759.6M 133.8M 52.4M -377.5M -110.8M 744.4M
Shares Outstanding (Basic)
145.9M 145.9M 145.7M 145.7M 145.6M 145.2M 144.9M 144.8M 144.7M 144.4M 144.1M 144.4M 145.9M 147.1M 146.9M 148M 149.7M 151.9M
Shares Outstanding (Diluted)
145.9M 145.9M 146.1M 145.9M 145.9M 145.9M 145.7M 144.8M 145.5M 145.2M 145.2M 144.8M 146.2M 147.6M 147.5M 148.6M 150.1M 152.3M
EPS (Basic)
10.50 10.16 11.22 11.11 7.97 8.05 8.03 10.13 18.46 21.62 20.99 19.68 14.04 9.79 10.43 10.25 12.50 19.10
EPS (Diluted)
10.49 10.14 11.19 11.07 7.94 8.01 7.98 10.06 18.37 21.54 20.93 19.64 14.02 9.77 10.40 10.22 12.46 19.06
EBITDA
2.79B 2.7B 2.83B 2.9B 2.25B 2.08B 2.01B 2.18B 3.07B 3.33B 3.27B 3.22B 2.76B 2.47B 2.89B 2.69B 3.33B 4.83B
EBIT
2.05B 1.99B 2.16B 2.27B 1.68B 1.67B 1.64B 1.84B 3.35B 3.93B 3.84B 3.65B 2.58B 1.88B 2B 1.94B 2.59B 4.06B
Depreciation & Amortization
744.3M 708.9M 673.2M 629.3M 571.5M 530M 494.8M 474.5M 470.2M 487.5M 518.4M 525.7M 537.7M 475.9M 435.3M 398.6M 380.6M 420.6M